Skip to main content

Table 3 Measurements at baseline, post-treatment, and 8 months of follow-up (n=10), (none lost to follow-up)

From: Feasibility and acceptability of somatocognitive therapy in the management of women with provoked localized vestibulodynia—ProLoVe feasibility study

 

Pre-treatment

Post-treatment

8 months of follow-up

Tampon test NRS (0-10), median (Q1; Q3)

4.5 (2.5; 6)

2 (1.5; 4.2)

3.5 (1.8; 4.5)

Intercourse past 4 weeks, n

2

6

7

FSFI, median (Q1; Q3)

 Total sum (0–36)

14.8 (9.8; 19.8)

22.8 (15.8; 25.4)

20.9 (18; 27.1)

 Desire

2.1 (1.6; 3.2)

3.6 (2.3; 3.8)

3.6 (2.7; 4.3)

 Arousal

3.2 (1.6; 4.9)

4.4 (2.7; 5.7)

4.4 (3.0; 5.6)

 Lubrication

4.2 (2.9; 5.2)

4.8 (3.5; 5.8)

4.7 (3.6; 6.0)

 Orgasm

3.2 (0.9; 5.3)

4.8 (2.6; 5.3)

4.8 (1.2; 5.2)

 Satisfaction

0.8 (0.4; 2.0)

4.2 (1.1; 5.2)

3.8 (1.2; 5.3)

 Pain

0.0 (0.0; 0.3)

1.8 (0.0; 3.6)

2.0 (0.0; 3.6)

PCS (0–52), median (Q1; Q3)

20 (15.3; 29.3)

9.5 (5.3; 20)

12.5 (6.3; 22)

HSCL-25, median (Q1; Q3)

2.0 (1.7; 2.5)

1.6 (1.3; 2.4)

1.8 (1.6; 2.2)

  1. NRS Numerical Rating Scale (higher scores indicate more pain), FSFI Female Sexual Function Index (higher scores indicate better sexual function), PCS Pain Catastrophizing Scale (higher scores indicate higher levels of catastrophizing, HSCL-25 Hopkins Symptom Check List - 25 (higher scores indicate higher levels of psychological distress)